Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05972096
Other study ID # IIBSP-TLP-2020-104
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date October 1, 2023

Study information

Verified date July 2023
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Juan Carlos Pascual, PhD
Phone 34935537840
Email jpascual@santpau.cat
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although borderline personality disorder (BPD) tend to the clinical remission in long-term follow-up studies, a significant subgroup of patients continues to present long lasting symptoms such as low mood, emptiness and persistent impairment in psychosocial adjustment. The prevalence of this subsample of individuals is considerably increasing last years. New interventions addressed to these individuals are need, the aim of this study is to evaluate the efficacy of a novel intervention combining dialectical behavioral therapy skills training with self-compassion and contextual-based skills for patients with long-lasting BPD.


Description:

Sixty individuals with BPD and long lasting symptoms that have been received previously dialectical-behavioral therapy skills training (DBT-ST) will be included in a randomized clinical trial. They will be randomly assigned to receive an add-on skills training intervention involving the combination of DBT-ST, self-compassion, and contextual-based skills for long lasting symptoms versus treatment as usual during 12-weeks. Patients will be evaluated pre and post intervention and 3-month follow-up. The outcome measures are well-being indicators and clinical variables.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 1, 2023
Est. primary completion date October 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Adults between 18 and 65 years of age - Primary diagnosis of BPD according to Diagnostic Statistical Manual IV criteria and by the structured interviews: Diagnosis Structured clinical interview for axis II personality disorders (SCID II; First et al. 1997) and Diagnostic Interview for Borderlines Revised (DIB-R) - Previous participation in DBT-ST intervention - Signed informed consent. Exclusion Criteria: - Presence of life-threatening behaviors in the last 12 months - PTSD or related symptoms - Diagnosis of drug-induced psychosis, organic brain syndrome, bipolar or psychotic disorder - Intellectual disability - Participation in any other psychotherapy treatment during the study.

Study Design


Intervention

Behavioral:
Combination DBT, self-compassion and contextual-based skills
Psychotherapy combination. Skills of DBT plus self-compassion and contextual skills

Locations

Country Name City State
Spain Juan Carlos Pascual Mateos Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pemberton Happiness Index (PHI) Happiness index (minimum 0- maximum 110) Higher scores better 1 month
Secondary Borderline Symptoms List-23 (BSL-23) Symptoms of Borderline (minimum 0- maximum 92). Higher scores worse 1 week
Secondary Remission from Depression Questionnaire (RDQ) Depression (minimum 0- maximum 84). Higher scores worse 1 week
Secondary Self Compassion Scale Short Form (SCS-SF) Compassion scale (12 items, minimum 12- maximum 60). Higher scores worse 1 month
Secondary Forms of Self-Criticism/Self-Attacking and Self-Reassuring Scale (FSCRS) Self-criticism forms (14 items, minimum 0- maximum 56). Higher scores worse 1 month
Secondary Satisfaction with life scale (SWLS) Well being (5 items, minimum 5 - maximum 25). Higher scores better 1 month
Secondary Quality of life scale (WHO-QOL_BREF) Quality of life OMS (26 items, minimum 26- maximum 130). Higher scores better 2 weeks
See also
  Status Clinical Trial Phase
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Not yet recruiting NCT05071638 - Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates Phase 3
Recruiting NCT04440670 - Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates Phase 3